Uncategorized

Open Source for Cost Effective Drug Discovery


Dr. Samir K Brahmachari, the new Director-General of the CSIR is all set to unleash the open source revolution in drug discovery and biotechnology. The Economic Times Reports: “For the first time ever, India plans to launch an innovate drug discovery programme roping in global IT firms, researchers, companies, and young minds at scientific laboratories to invent drugs at a fraction of the cost of an MNC-developed drug. Drug discovery has hitherto been the forte of MNC pharma giants. The…


Read More »
Copyright

Moral Rights Under Copyright Laws: A Peep Into Policy – 2


As promised in my previous post, here’s more on moral rights and related policies. To start where I’d stopped, this week we are looking at an interesting survey (albeit a little dated) conducted by the Copyright Office in the US in the mid 90’s to review the waiver provision’s operation to “assure that artists were not coerced by unequal bargaining power to forfeit their moral rights.” The survey “[sought] comments on artists’ bargaining power relative to that of commercial users…


Read More »

Basmati redux: the Pashmina story


You can see them being sold everywhere: in the open-air stalls of Dilli Haat in the capital; in the crowded, winding lanes of Chinatown in Singapore; in the fashionable streets by the Hotel de Ville in Paris… Pashmina shawls, both real and fake, have become a global fashion statement, and can be found draped around every neck this winter. But where exactly do they originate? In a replay of the Super Basmati yarn, troubles between India and Pakistan have been…


Read More »

SpicyIP Tidbits


1. Pfizer gets a patent for its anti-HIV drug Pfizer was recently granted a patent, by the Indian Patent office, for its HIV/AIDS treatment drug – Celzentry. This is a significant victory for Pfizer given the much publicized rejection of patents for several other drugs. Given the huge HIV infected population in India it is expected that this drug will be a major revenue spinner for Pfizer in India. As a result Pfizer’s stock shot up 7.5% on the Indian…


Read More »

SpicyIp Tidbits


1. India says No to Removal of Trade Barriers. 1ndia on Saturday was at the forefront with Brazil, opposing a proposal of developed nations seeking removal of trade barriers to allow transfer of clean technologies. The European Union and the United States made a joint proposal through the World Trade Organization to remove specific barriers to trade in clean energy technologies like wind turbines and solar panels as part of the long- running Doha round of talks. Both India and…


Read More »
Uncategorized

An Indian DMCA?


We recently posted a note on Spicy tidbits about the increase in copyright notices to Indian ISPs. I picked this up and posted over at IP Think Tank about the increased pressure on ISPs around the world. One suggestion (by Will), was that the world should take note of the Digital Millenium Copyright Act (DMCA) in the United States and follow suit. Canada are about to do this (though with some controversy). For those who don’t know the detail, it…


Read More »

SpicyIP Tidbits


1. Who’s really winning the IP race in India? Joff Wild, of Intellectual Asset Magazine, comments on the patent explosion in India, and who appear to be the actual beneficiaries of the policy changes in Indian IP … Worryingly for India, perhaps, is the fact that 80% of applications come from foreign companies… It seems to me that if India is to realise its huge potential, and the undoubted creativity of its population, a lot more work needs to be…


Read More »

"TECHNOLOGY" SOLUTION FOR PARALLEL IMPORTS?


Rosica PR News reports that: “Secure Symbology, a New Jersey-based business that has successfully developed and implemented the only tested and proven anti-counterfeiting solution for pharmaceuticals, has been named “Emerging Business of the Year” by NJBiz. The counterfeiting of pharmaceutical drugs is a serious issue that poses a real threat to the unsuspecting public, and many consumers who rely on prescription medications have suffered catastrophic consequences to their health by consuming fake, or even toxic, prescriptions. Founded in 2003 and…


Read More »

"TECHNOLOGY" SOLUTION FOR PARALLEL IMPORTS?


Rosica PR News reports that: “Secure Symbology, a New Jersey-based business that has successfully developed and implemented the only tested and proven anti-counterfeiting solution for pharmaceuticals, has been named “Emerging Business of the Year” by NJBiz. The counterfeiting of pharmaceutical drugs is a serious issue that poses a real threat to the unsuspecting public, and many consumers who rely on prescription medications have suffered catastrophic consequences to their health by consuming fake, or even toxic, prescriptions. Founded in 2003 and…


Read More »
Biological Diversity

Bringing about compatibility between TRIPS and the CBD


Livemint’s Unnikrishnan reported recently that there has been a move in the Council of TRIPS to ensure compulsory disclosure, by patent applicants, of the origin of genetic materials used in their inventions. SpicyIP in one of its earlier posts had mentioned that the Indian Biological Diversity Act requires that any patenting of genetic material in India be done only with the prior authorization of the National Biological Diversity Authority. Livemint quotes SpicyIP’s Shamnad Basheer saying that it is not quite…


Read More »